Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Paediatric therapeutic development workshop on osteosarcoma.
Journal: British journal of cancer
Published: April 07, 2026
SMARCAL1 is a candidate therapeutic target for ALT-positive tumors.
Journal: bioRxiv : the preprint server for biology
Published: February 27, 2026
Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in MYOD1-mutant rhabdomyosarcoma.
Journal: Science advances
Published: February 27, 2026
Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in MYOD1-mutant rhabdomyosarcoma.
Journal: Science advances
Published: February 27, 2026
Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.
Journal: Cancers
Published: January 29, 2026
SMARCAL1 is a candidate therapeutic target for ALT-positive tumors.
Journal: Genes & development
Published: September 25, 2025
A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.
Journal: Cancer research
Published: September 03, 2025
Author Correction: Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers.
Journal: Nature communications
Published: September 03, 2025
Author Correction: Clonal evolution during metastatic spread in high-risk neuroblastoma.
Journal: Nature genetics
Published: August 06, 2025
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibition.
Journal: Molecular cancer therapeutics
Published: June 03, 2025
Last Updated: 09/26/2026